On this page
Asset Type
Manufacturer
Model
What This Guide Helps With
Troubleshoots processing-quality concerns, verification failures, and inconsistent tissue-processing outcomes while separating equipment conditions from reagent, protocol, and specimen factors.
Step-by-Step Troubleshooting
1. Protect Patient Specimens
If laboratory staff report unacceptable processing quality, stop using the processor for additional patient specimens until the scope of the issue is understood.
Affected specimens must be managed by qualified laboratory personnel.
Expected outcome: Additional specimens are not exposed to a potentially unreliable processing condition.
2. Define the Reported Quality Problem
Ask laboratory staff what was observed and whether the issue involves one specimen, one batch, multiple runs, or all specimens processed on the unit.
Determine when the problem began and whether a specific processing program, reagent set, or workflow is involved.
Expected outcome: The pattern of the processing-quality complaint is clearly defined.
3. Review Device Status and Event Information
Check the processor for active or recent warnings, incomplete cycles, power interruptions, fluidics warnings, temperature-related conditions, or other operational abnormalities associated with the affected run.
Do not infer a hardware failure solely from the tissue result.
Expected outcome: Any equipment-generated indication relevant to the affected cycle is identified.
4. Verify Reagent Setup
With laboratory staff, confirm that required reagents were present, correctly positioned, suitable for use under laboratory procedures, and represented correctly in the system.
Look for obvious container, connection, leakage, or inventory discrepancies.
Expected outcome: The reagent setup is verified or an external reagent-related cause is identified.
5. Verify the Processing Program
Have authorized laboratory staff confirm that the intended processing program was selected for the affected specimens and that no unauthorized settings or protocol changes occurred.
Clinical Engineering should not independently alter clinical processing protocols.
Expected outcome: The correct program was used, or a workflow/configuration discrepancy is identified.
6. Check for Facility or Environmental Events
Determine whether the affected processing period coincided with a power interruption, relocation, temperature problem, utility issue, maintenance event, or other environmental change.
Expected outcome: External facility conditions are either identified as a contributing factor or ruled out.
7. Compare With Previous and Other-System Results
When available, ask laboratory staff whether similar specimens processed on another verified processor produced acceptable results and whether prior runs on this unit were normal.
This helps distinguish a device-specific trend from specimen, reagent, or laboratory-process variation.
Expected outcome: The comparison narrows the problem to the processor or identifies a broader workflow/reagent issue.
8. Perform Approved Operational Verification
With the processor free of patient specimens, perform only approved functional checks appropriate to Clinical Engineering and the available manufacturer documentation.
Do not use patient tissue as a technical test load.
Expected outcome: The processor either demonstrates normal operation or reproduces an equipment-related abnormal condition.
9. Confirm Suitability Before Return to Service
Return the processor to use only after the suspected cause has been corrected and laboratory personnel are satisfied that required quality verification has been successfully completed.
Expected outcome: Processing quality and device operation have been appropriately verified. Troubleshooting can stop.
If the Problem Persists
If reagent setup, processing-program selection, device status, facility conditions, recent changes, and approved functional checks have been evaluated without identifying an external cause, common external causes have been ruled out.
Possible remaining categories include internal temperature, pressure, vacuum, agitation, fluid-transfer, sensing, control, software, or other service-level problems.
The device should be:
- Removed from service.
- Labeled Out of Service.
- Sent for qualified repair or service evaluation.
- Evaluated using appropriate Sakura Finetek documentation and approved test equipment.
- Repaired or configured only by qualified personnel.
Clinical Engineering should not declare specimen-processing performance acceptable without the appropriate laboratory quality verification. Complete applicable technical and laboratory verification before return to service.
Knowing when to stop external troubleshooting is proper troubleshooting.
Clinical Use Tip
Poor tissue-processing quality should be treated as a specimen-integrity concern even when the processor shows no obvious equipment alarm.
Work Order Documentation (CCR Method)
CCR = Complaint, Cause, Resolution
Complaint
What was reported by the clinical staff.
Example:
"Laboratory staff reported inconsistent tissue-processing quality from specimens processed on the Tissue-Tek VIP 6 AI."
Cause
What was observed during troubleshooting.
Example:
"Clinical Engineering and laboratory staff found that the installed reagent configuration did not match the intended processing setup."
Resolution
What action was taken.
Example:
"Laboratory staff corrected the reagent configuration, Clinical Engineering verified normal processor operation, required laboratory quality checks were completed, and the unit was returned to service."
Helpful Details to Include (If Known)
- Description of the observed processing problem
- Number of affected specimens or runs
- Processing program used
- Reagent configuration
- Device warnings or events
- Power or facility events
- Recent cleaning or maintenance
- Comparison with another processor
- Functional verification results
- Laboratory acceptance before return to service
Final Thought
Protect specimens first, investigate reagent, workflow, configuration, and facility factors before assuming equipment failure, and require appropriate verification before returning an implicated tissue processor to service.
That is successful troubleshooting.